However, Bowser et al. showed loss of CD73 to be essential for endometrial tumour progression [201], while Kurnit et al. reported the critical role of CD73 in the tumour-suppressive activity of TGF-β1 in endometrial carcinoma [202]. Here, NT5E is linked to endometrial carcinoma.